Qubit Pharmaceuticals

About:

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

Website: https://www.qubit-pharmaceuticals.com

Top Investors: European Innovation Council, XAnge, Omnes Capital, Quantonation, Octave Klaba

Description:

Qubit Pharmaceuticals is a brand-new international company based in Paris that was founded by CNAM, CNRS, the University of Texas at Austin, the Sorbonne University, and Washington University. Qubit Pharmaceuticals is built on more than 20 years of R and D that has been recognized with the most prestigious awards. It was founded by Pr Jay Ponder, Pr Pengyu Ren, Pr J.-P. Piquemal, Dr Louis Lagardere, and Pr Matthieu Montes.

Total Funding Amount:

18.6M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2020-01-01

Founders:

Jay Ponder, Jean- Philip Piquemal, Matthieu Montes

Number of Employees:

11-50

Last Funding Date:

2022-06-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai